Antireflux Metal Stent as a First-Line Metal Stent for Distal Malignant Biliary Obstruction: A Pilot Study
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: In distal malignant biliary obstruction, an antireflux metal stent (ARMS) with a funnel-shaped valve is effective as a reintervention for metal stent occlusion caused by reflux. This study sought to evaluate the feasibility of this ARMS as a first-line metal stent. Methods: Patients with nonresectable distal malignant biliary obstruction were identified between April and December 2014 at three Japanese tertiary centers. We retrospectively evaluated recurrent biliary obstruction and adverse events after ARMS placement. Results: In total, 20 consecutive patients were included. The most common cause of biliary obstruction was pancreatic cancer (75%). Overall, recurrent biliary obstruction was observed in seven patients (35%), with a median time to recurrent biliary obstruction of 246 days (range, 11 to 246 days). Stent occlusion occurred in five patients (25%), the causes of which were sludge and food impaction in three and two patients, respectively. Stent migration occurred in two patients (10%). The rate of adverse events associated with ARMS was 25%: pancreatitis occurred in three patients, cholecystitis in one and liver abscess in one. No patients experienced nonocclusion cholangitis. Conclusions: The ARMS as a first-line biliary drainage procedure was feasible. Because the ARMS did not fully prevent stent dysfunction due to reflux, further investigation is warranted.
Abstract
Background/Aims: In distal malignant biliary obstruction, an antireflux metal stent (ARMS) with a funnel-shaped valve is effective as a reintervention for metal stent occlusion caused by reflux. This study sought to evaluate the feasibility of this ARMS as a first-line metal stent. Methods: Patients with nonresectable distal malignant biliary obstruction were identified between April and December 2014 at three Japanese tertiary centers. We retrospectively evaluated recurrent biliary obstruction and adverse events after ARMS placement. Results: In total, 20 consecutive patients were included. The most common cause of biliary obstruction was pancreatic cancer (75%). Overall, recurrent biliary obstruction was observed in seven patients (35%), with a median time to recurrent biliary obstruction of 246 days (range, 11 to 246 days). Stent occlusion occurred in five patients (25%), the causes of which were sludge and food impaction in three and two patients, respectively. Stent migration occurred in two patients (10%). The rate of adverse events associated with ARMS was 25%: pancreatitis occurred in three patients, cholecystitis in one and liver abscess in one. No patients experienced nonocclusion cholangitis. Conclusions: The ARMS as a first-line biliary drainage procedure was feasible. Because the ARMS did not fully prevent stent dysfunction due to reflux, further investigation is warranted.
참고문헌 (34)
- Davids PH, "Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction", Lancet, 340, pp.1488~1492 (1992)
- Knyrim K, "A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct", Endoscopy, 25, pp.207~212 (1993)
- Lammer J, "Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents", Radiology, 201, pp.167~172 (1996)
- Isayama H, "Results of a Japanese multicenter, randomized trial of endoscopic stenting for nonresectable pancreatic head cancer (JM-test): covered Wallstent versus DoubleLayer stent", Dig Endosc, 23, pp.310~315 (2011)
- Isayama H, "Polyurethane-covered metal stent for management of distal malignant biliary obstruction", Gastrointest Endosc, 55, pp.366~370 (2002)
- Isayama H, "A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
- Nakai Y, "Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction", Gastrointest Endosc, 62, pp.742~748 (2005)
- Saleem A, "Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction", Gastrointest Endosc, 74, pp.321~327.e3 (2011)
- Kitano M, "Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial", Am J Gastroenterol, 108, pp.1713~1722 (2013)
- Okamoto T, "Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis", Gastrointest Endosc, 63, pp.792~796 (2006)
- Misra SP, "Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement", astrointest Endosc, 70, pp.317~321 (2009)
- Wen F, "Bridging across the ampulla with metal stents: evidences for intestinal bile reflux", Hepatogastroenterology, 60, pp.1903~1905 (2013)
- Hu B, "A novel antireflux metal stent for the palliation of biliary malignancies: a pilot feasibility study (with video)", Gastrointest Endosc, 73, pp.143~148 (2011)
- Lee KJ, "Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction", Dig Endosc, 25, pp.308~312 (2013)
- Hamada T, "Novel antireflux covered metal stent for recurrent occlusion of biliary metal stents: a pilot study", Dig Endosc, 26, pp.264~269 (2014)
- Hu B, "Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial", Endoscopy, 46, pp.120~126 (2014)
- Schmassmann A, "Wallstents versus plastic stents in malignant biliary obstruction:effects of stent patency of the first and second stent on patient compliance and survival", Am J Gastroenterol, 91, pp.654~659 (1996)
- Ornellas LC, "Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention", Gastrointest Endosc, 70, pp.676~683 (2009)
- Togawa O, "Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction", J Gastroenterol, 48, pp.1300~1307 (2013)
- Kim DU, "New antireflux selfexpandable metal stent for malignant lower biliary obstruction: in vitro and in vivo preliminary study", Dig Endosc, 25, pp.60~66 (2013)
- Isayama H, "Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent", Surg Endosc, 24, pp.131~137 (2010)
- Nakai Y, "New method of coveredwallstents for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics", Dig Endosc, 23, pp.49~55 (2011)
- Hamada T, "Tips and troubleshooting for transpapillary metal stenting for distal malignant biliary obstruction", J Hepatobiliary Pancreat Sci, 21, pp.E12~E18 (2014)
- Nakai Y, "Impact of introduction of wire-guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography", J Gastroenterol Hepatol, 26, pp.1552~1558 (2011)
- Isayama H, "TOKYO criteria 2014 for transpapillary biliary stenting", Dig Endosc, 27, pp.259~264 (2015)
- Kawakubo K, "Risk factors for pancreatitis following transpapillary self-expandable metal stent placement", Surg Endosc, 26, pp.771~776 (2012)
- Almadi MA, "No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis", Clin Gastroenterol Hepatol, 11, pp.27~37.e1 (2013)
- Isayama H, "Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction:the WATCH study", Gastrointest Endosc, 76, pp.84~92 (2012)
- Moon SH, "Modified fully covered selfexpandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration", Gastrointest Endosc, 72, pp.86~91 (2010)
- Hamada T, "Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer", Gastrointest Endosc, 74, pp.548~555 (2011)
- Lee YN, "Effectiveness of a newly designed antireflux valve metal stent to reduce duodenobiliary reflux in patients with unresectable distal malignant biliary obstruction:a randomized, controlled pilot study (with videos).", Gastrointest Endosc, 83, pp.404~412 (2016)
- Telford JJ, "A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction", Gastrointest Endosc, 72, pp.907~914 (2010)
- Kullman E, "Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study", Gastrointest Endosc, 72, pp.915~923 (2010)
- Hamada T, "Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate", Surg Endosc, 27, pp.1243~1248 (2013)